Cargando…

Parathyroid hormone is associated with prostate cancer

BACKGROUND: The present study investigated the association of serum parathyroid hormone (PTH), vitamin D, and calcium levels with prostate cancer (CaP). METHODS: The study population consisted of an experimental group [459 patients including 216 patients with CaP and 243 patients with benign prostat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Won Tae, Bang, Woo Jin, Seo, Sung Pil, Kang, Ho Won, Byun, Young Joon, Piao, Xuan-Mei, Jeong, Pildu, Shin, Kyung-Sub, Choi, Song-Yi, Lee, Ok-Jun, Kim, Yong-June, Lee, Sang Cheol, Yun, Seok Joong, Kim, Wun-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557196/ https://www.ncbi.nlm.nih.gov/pubmed/33102392 http://dx.doi.org/10.1016/j.prnil.2020.02.002

Ejemplares similares

Role of 1,25-Dihydroxy Vitamin D(3) and Parathyroid Hormone in Urinary Calcium Excretion in Calcium Stone Formers
por: Kim, Won Tae, et al.
Publicado: (2014)

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer
por: Lee, Il-Seok, et al.
Publicado: (2017)

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2016)

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
por: Kang, Ho Won, et al.
Publicado: (2020)

Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer
por: Byun, Young Joon, et al.
Publicado: (2021)

CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2018)

A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy
por: Kim, Seon-Kyu, et al.
Publicado: (2021)

Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
por: Kang, Ho Won, et al.
Publicado: (2019)

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
por: Kim, Won Tae, et al.
Publicado: (2018)

Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone
por: Kang, Ho Won, et al.
Publicado: (2022)

Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer
por: Byun, Young Joon, et al.
Publicado: (2022)

Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer
por: Kim, Young-Won, et al.
Publicado: (2015)

Chronological Trends in Clinical and Urinary Metabolic Features over 20 Years in Korean Urolithiasis Patients
por: Kang, Ho Won, et al.
Publicado: (2017)

Elevated Insulin and Insulin Resistance Are Associated with the Advanced Pathological Stage of Prostate Cancer in Korean Population
por: Yun, Seok Joong, et al.
Publicado: (2012)

A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
por: Piao, Xuan-Mei, et al.
Publicado: (2020)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
por: Piao, Xuan-Mei, et al.
Publicado: (2022)

Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinoma
por: Kang, Ho Won, et al.
Publicado: (2021)

A high basal metabolic rate is an independent predictor of stone recurrence in obese patients
por: Kang, Ho Won, et al.
Publicado: (2021)

Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer
por: Yoon, Hyung-Yoon, et al.
Publicado: (2013)

Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study
por: Kang, Ho Won, et al.
Publicado: (2017)

Effect of Renal Insufficiency on Stone Recurrence in Patients with Urolithiasis
por: Kang, Ho Won, et al.
Publicado: (2014)

Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study
por: Kang, Ho Won, et al.
Publicado: (2016)

Trends in clinical, operative, and pathologic characteristics of surgically treated renal mass in a Korean center: A surgical series from 1988 through 2015
por: Kang, Ho Won, et al.
Publicado: (2019)

Docetaxel-Induced Fatal Interstitial Pneumonitis in a Patient with Castration-Resistant Prostate Cancer
por: Min, Byung-Dal, et al.
Publicado: (2012)

DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis
por: Yoon, Hyung-Yoon, et al.
Publicado: (2012)

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
por: Park, Jong-Lyul, et al.
Publicado: (2018)

Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria
por: Kim, Won Tae, et al.
Publicado: (2016)

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer
por: Lee, Jong-Young, et al.
Publicado: (2018)

Unusual Manifestation of Intravascular Large B-Cell Lymphoma: Severe Hypercalcemia with Parathyroid Hormone-Related Protein
por: Ha, Jung Min, et al.
Publicado: (2014)

Impact of Transobturator Tape Treatment on Overactive Bladder Symptoms, Particularly Nocturia, in Patients With Mixed Urinary Incontinence
por: Lee, Sang Keun, et al.
Publicado: (2014)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Usefulness of a Combined Approach of T1-Weighted, T2-Weighted, Dynamic Contrast-Enhanced, and Diffusion-Weighted Imaging in Prostate Cancer
por: Min, Byung Dal, et al.
Publicado: (2012)

Diagnostic Role of Prostate Resection in the Elderly Patients Who Experience Significant Co-Morbidity with a High Clinical Suspicion of Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2013)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

Tubal Buccal Mucosa Graft without Anastomosis of the Proximal Urethra for Long Segment Posterior Urethral Defect Repair
por: Min, Byung-Dal, et al.
Publicado: (2012)

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer
por: Yan, Chunri, et al.
Publicado: (2015)

For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
por: Kim, Won Tae, et al.
Publicado: (2019)

Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b1o90cmqap0lcp5arp9ipe92li